Allergan Inc.’s move into medical cosmetics,wrinkle removers, an obesity device and breast implants,has a name. Earlier this month, the Irvine drug maker unveiled a new division, Allergan Medical, ...

DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced clinical study results of higher doses of BOTOX ® Cosmetic compared to BOTOX ® Cosmetic 20 unit dose at week 24 in ...

Allergan has been working on a plan to hive off its women’s health and infectious disease units—much to the chagrin of some investors who were hoping the company would embrace a more drastic strategy ...

NEW YORK (Reuters) - Allergan Plc said revenue from its medical aesthetics business could double by 2025, even as it faces increasing competition for its blockbuster wrinkle treatment, Botox. The ...

The FINANCIAL — Allergan plc on May 23 announced that the Japanese Ministry of Health, Labour and Welfare has approved an additional use for BOTOX Vista (Allergan’s botulinum toxin type A product) as ...

(Reuters) - Allergan Plc on Tuesday expressed disappointment in early offers from potential buyers for business units it has been trying to sell, and its shares fell more than 6 percent. Allergan has ...

Irvine-based Allergan Inc., maker of wrinkle-fighting Botox and other drugs, is gaining more attention on Wall Street. At least one analyst even crafted a pun—intended or otherwise—to lay out a case ...

IRVINE, Calif., Nov. 16, 2020 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX ® Cosmetic Day on Wednesday, November 18, 2020. The event is ...

Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...

(Reuters) - Allergan Plc on Tuesday forecast 2019 revenue below expectations on looming competition for some of its top drugs, and shelved plans to sell its women's health business. The Botox maker's ...

Allergan Inc. said Tuesday that it will spin off the eye-care business that built the company and allowed it to develop popular skin-care and drug products, which now will become the core of the ...

AbbVie and Allergan have waited expectantly to seal the deal on their $63 billion merger as international watchdogs took a close look at the combo. Now, they're almost home free. The EU says it's ...